November 9, 2017 — Abbott received European CE mark for Xience Sierra, the newest generation of the company's Xience ...
November 3, 2017 — Here is the list of the most popular articles and videos on the Diagnostic and Interventional ...
October 31, 2017 – Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting bioresorbable vascular ...
October 31, 2017 — The U.S. Food and Drug Administration (FDA) issued a warning to healthcare providers that interim ...
October 23, 2017 – The U.S. Food and Drug Administration (FDA) has cleared Abbott’s Confirm Rx Insertable Cardiac ...
September 22, 2017 — Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR) ...
September 8, 2017 — Abbott Vascular has announced it will end commercial sales of its Absorb bioresorbable vascular ...
September 5, 2017 — Minneapolis Heart Institute Foundation announced it has enrolled the first-in-the-world patient in a ...
September 5, 2017 — Abbott announced it has initiated a U.S. pivotal clinical study evaluating the safety and ...
August 29, 2017 — Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev ...